Latest Leadership Change News

Energy Resources of Australia (ERA) reports a robust cash position following a $766 million entitlement offer, advancing rehabilitation at its Ranger Project while seeking to extend its operational authority beyond January 2026.

DomaCom Limited reported a steep $4.5 million loss for the half-year ending December 2023, driven by declining revenues and operational hurdles, including a temporary suspension of its fund's Product Disclosure Statement. The company is actively pursuing capital raises to stabilize its position.

Thor Energy PLC advances its clean energy ambitions through a strategic acquisition in South Australia's hydrogen sector and promising uranium drilling results in the US.

Key Petroleum Limited progresses Potential Commercial Area applications for ATPs 920 and 924 in Queensland’s Cooper Eromanga Basin, supported by a recent capital raise despite a constrained cash balance.

I Synergy Group Limited has reshaped its board with the resignation of Joshua Hunt, the appointment of Jiayi Yu as Non-Executive Director, and the promotion of Heng Jee Meng to Managing Director, signaling a renewed focus on shareholder value.

Biotron Limited has engaged US-based C14 Consulting Group to drive strategic partnerships for its antiviral drug portfolio, including lead candidate BIT225, while advancing its Hepatitis B research.

IPB Petroleum has appointed a new chairman and is intensifying efforts to secure funding for drilling its key Browse Basin assets, while maintaining a strong cash position and exploring new project opportunities.

Tower Limited has appointed CFO Paul Johnston as interim CEO following Blair Turnbull's resignation, with Deputy CFO Angus Shelton stepping in as interim CFO pending regulatory approval.

Mayfield Childcare is nearing the appointment of a new CEO while enacting significant board changes, including the elevation of Lubna Matta to Executive Director and Roseanne Healy to Chair.

The Calmer Co. International Limited has reported a remarkable surge in sales and cash receipts for the first half of FY25, exceeding the entire FY24 sales. Alongside a strategic CEO transition and factory upgrade, the company is sharpening its focus on profitable growth and cost control.

Emyria Limited announces key leadership shifts with Greg Hutchinson stepping up as Executive Chairman and Dr. Michael Winlo transitioning to Chief Scientific Officer, aiming to scale innovative mental health therapies amid growing demand.

Mighty Kingdom Ltd has appointed Dylan Miklashek as Interim CEO and Duncan Gordon as Non-Executive Chair, signaling a fresh leadership approach amid a company restructuring.